Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 24, 2018

What's News This Morning

Earnings, earnings, earnings. Here is a brief summary of the news – and all positive!

  1. China apparently decided to print more money, build more speed trains, wonderful airports, more freeways. This is their response to a possible trade war (or not?) 
  2. One of the largest European banks – UBS - just reported great earnings. 
  3. Manufacturing index out of Germany is much better than expected. 
  4. On this side of the pond, earnings continue to impress – Google yesterday was a pleasant surprise, but others (Verizon, Biogen, Eli Lily, Lockheed Martin) are doing very well.
  5. 10 year Treasuries yield is approaching 3% again and the gap between 2-year Treasuries and 10-years is increasing again.

Are we out of the woods?

Related Ticker: BIIB

BIIB in downward trend: price may drop because broke its higher Bollinger Band on March 11, 2024

BIIB broke above its upper Bollinger Band on March 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 37 similar instances where the stock broke above the upper band. In of the 37 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 22, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on BIIB as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BIIB entered a downward trend on March 12, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BIIB's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for BIIB just turned positive on March 27, 2024. Looking at past instances where BIIB's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIIB advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BIIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.118) is normal, around the industry mean (5.796). P/E Ratio (27.055) is within average values for comparable stocks, (49.835). BIIB's Projected Growth (PEG Ratio) (8.807) is slightly higher than the industry average of (3.059). BIIB's Dividend Yield (0.000) is considerably lower than the industry average of (0.029). P/S Ratio (3.192) is also within normal values, averaging (3.722).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 87.73B. The market cap for tickers in the group ranges from 72.83K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -2%. SCLX experienced the highest price growth at 13%, while MIRA experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 13% and the average quarterly volume growth was -0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 29
P/E Growth Rating: 61
Price Growth Rating: 50
SMR Rating: 58
Profit Risk Rating: 70
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
BIIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com
Ad is loading...
Discover the dynamic world of cryptocurrency trading with Tickeron's AI analysis. Capitalize on bullish and bearish patterns in Origin Protocol (OGN.X), with gains up to 27.80%. Stay ahead with Tickeron's real-time insights and make informed trading decisions. #CryptoTrading #AIAnalysis #OriginProtocol #InvestSmart
#latest#popular#patterns#artificial_intelligence#trading#technical_analysis
Dive into the world of trading excellence with our Best AI Robot of the week! In a market characterized by growth, the key to maximizing profits lies not only in mainstream large-cap stocks but also in exploring opportunities across different market segments.
This article delves into the performance of AI trading robots, specifically those utilizing the "Swing trader: Long-Short Equity Strategy (TA&FA)." These bots showcased their prowess by delivering a notable +4.98% gain while engaging in MRNA trades over the previous week. Beyond mere statistics, we explore the technical indicators and recent earnings report of MRNA to shed light on the underlying dynamics influencing the stock.
Artificial intelligence (AI) trading bots have become powerful tools for investors seeking active trading opportunities. In a recent analysis conducted on the "Day Trader: High Volatility Stocks for Active Trading (TA&FA)" platform, AI trading bots exhibited impressive performance, generating a noteworthy +4.81% gain while actively trading Shopify (SHOP) over the course of the previous week.
In the dynamic world of finance, strategic asset acquisition is a game-changer. Recently, a group of stocks within this domain has been in the spotlight, showcasing notable performances and intriguing patterns. This article delves into the recent movements of these stocks, focusing on key indicators, market capitalization, notable price events, and volume dynamics.
Urology companies, comprising EDAP (EDAP), Teleflex (TFX), and UroGen Pharma (URGN), have shown a remarkable +6.67% increase in performance over the last week. In this analysis, we delve into various indicators and metrics to better understand the current landscape and individual trajectories within this thematic sector.
In the ever-evolving landscape of financial markets, Artificial Intelligence (AI) trading robots have emerged as potent tools for investors seeking an edge. The recent performance of the AI trading robots accessible through "Swing Trader, Popular Stocks: Short Bias Strategy (TA&FA)" has caught the attention of market participants. Notably, these bots generated an impressive +10.22% gain in a week, with a focus on trading TSM (Taiwan Semiconductor Manufacturing Company).
In the fast-paced world of stock trading, artificial intelligence (AI) has become a game-changer, with trading robots demonstrating impressive results. The "Day Trader: Medium Volatility Stocks for Active Trading (TA&FA)" platform recently showcased the effectiveness of its bots, generating a notable +7.86% gain while actively trading AMD over the past week.
​​​​​​​Aluminum companies have witnessed a remarkable surge in performance, with a collective increase of +8.75% over the past week. In this analysis, we delve into the dynamics of this surge, focusing on key indicators and individual stock movements. The tickers in focus are CENX, AA, KALU, and CSTM.
​​​​​​​Propane gas companies, represented by tickers NGL, SGU, and SPH, have exhibited a remarkable +8.22% increase in performance over the past week. This surge is substantiated by various technical indicators, fostering a positive outlook for investors. In this analysis, we delve into key indicators, market capitalization, notable price movements, and volume fluctuations to provide a comprehensive understanding of the current landscape.
The Tickeron quant team is delighted to introduce our best robot of the week tailored for Trend Traders. Our sophisticated AI Robot, has been designed for manual trading enthusiasts who value independent signal selection.
In the fast-paced world of AI trading, algorithms powered by sophisticated technical analysis tools are making waves. The "Swing trader: Top High-Volatility Stocks v.2 (TA)" bots have proven their mettle, securing a remarkable +6.02% gain in a week of trading AVGO.
Artificial intelligence (AI) trading robots have become an integral part of the market landscape. One such example is the "Swing Trader, Popular Stocks: Short Bias Strategy (TA&FA)" bot, which showcased impressive results with a +5.54% gain while trading LRCX over the past week. In this article, we delve into the technical analysis of LRCX, examining its recent earnings report and broader industry trends.
The drilling industry has recently experienced a commendable upswing, with a substantial 8.22% surge in performance over the past week. In this article, we will dissect the current dynamics of key players in this sector, focusing on prominent tickers such as DO, RIG, HP, NBR, NR, PDS, and PTEN.
In the realm of AI-driven trading, the "Swing Trader: ETFs for Growing Industries (TA)" platform recently showcased impressive results, with its trading bots generating a noteworthy +5.09% gain while actively trading TQQQ over the past week. As we delve into the intricacies of these AI trading strategies, let's dissect the recent earning results and market indicators to better understand the driving forces behind their success.
In the fast-paced world of AI-driven trading, the utilization of sophisticated algorithms and technical analysis tools is becoming increasingly prevalent. One notable example is the Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA), which demonstrated its prowess by generating a commendable +5.02% gain while trading NVDA over the past week. Let's delve into the technical indicators and earnings results to gain a comprehensive understanding of NVDA's current market standing.
In the fast-paced realm of biotech and pharmaceuticals, a group of stocks, including giants like Johnson & Johnson (JNJ), Amgen (AMGN), Pfizer (PFE), Astex Pharmaceuticals (ATXS), AnaptysBio (ANAB), and Zymeworks (ZYME), witnessed a noteworthy 8.55% surge in performance over the past week. However, a closer look at various indicators suggests caution, signaling a potential downturn.
In the dynamic landscape of the energy sector, onshore oil exploration companies have recently experienced a remarkable upswing, with a notable 7.13% increase in performance over the past week. This surge has captivated market attention, and several key indicators point towards a sustained positive outlook. In this analysis, we delve into the financial health, market dynamics, and recent events surrounding prominent tickers in this domain - PXD, CNQ, PDS, PTEN, and FANG.
Tickeron's Quant team is delighted to introduce our latest AI-powered robot designed for trading small-cap stocks, employing a distinctive fundamental stock analysis algorithm. This algorithm, renowned for its blend of in-depth analysis and intuitive signal-following capabilities, is well-suited for both novice and seasoned traders.
In the dynamic world of stock trading, the utilization of AI trading robots has become increasingly prevalent. One such example is the "Trend Trader, Popular Stocks: Price Action Trading Strategy (TA&FA)," which showcased its prowess by yielding a remarkable +4.98% gain while trading ZIM over the previous week. As we delve into the intricacies of ZIM's recent performance, let's analyze the earnings results, market indicators, and industry trends that shape the narrative.